Prolastin (Talecris Biotherapeutics C formerly Bayer)
Prolastin (Talecris Biotherapeutics C formerly Bayer) Brand names, Prolastin (Talecris Biotherapeutics C formerly Bayer) Analogs
Prolastin (Talecris Biotherapeutics C formerly Bayer) Brand Names Mixture
- No information avaliable
Prolastin (Talecris Biotherapeutics C formerly Bayer) Chemical_Formula
C2001H3130N514O601S10
Prolastin (Talecris Biotherapeutics C formerly Bayer) RX_link
http://www.rxlist.com/cgi/generic3/zemaira.htm
Prolastin (Talecris Biotherapeutics C formerly Bayer) fda sheet
Prolastin (Talecris Biotherapeutics C formerly Bayer) msds (material safety sheet)
Prolastin (Talecris Biotherapeutics C formerly Bayer) Synthesis Reference
No information avaliable
Prolastin (Talecris Biotherapeutics C formerly Bayer) Molecular Weight
44324.5
Prolastin (Talecris Biotherapeutics C formerly Bayer) Melting Point
59 oC at pH 7.8 (Tew D.J., Bottomley, S.P. J. Mol. Biol. 313:1161-1169 (2001)).
Prolastin (Talecris Biotherapeutics C formerly Bayer) H2O Solubility
No information avaliable
Prolastin (Talecris Biotherapeutics C formerly Bayer) State
Liquid
Prolastin (Talecris Biotherapeutics C formerly Bayer) LogP
-0.302
Prolastin (Talecris Biotherapeutics C formerly Bayer) Dosage Forms
Powder for solution; Solution (IV)
Prolastin (Talecris Biotherapeutics C formerly Bayer) Indication
For treatment of panacinar emphysema
Prolastin (Talecris Biotherapeutics C formerly Bayer) Pharmacology
Prevents excessive accumulation of active neutrophil elastase and consequent proteolysis of elastin tissues in alveolar lung structures. This prevents the development of emphysema.
Prolastin (Talecris Biotherapeutics C formerly Bayer) Absorption
No information avaliable
Prolastin (Talecris Biotherapeutics C formerly Bayer) side effects and Toxicity
No information avaliable
Prolastin (Talecris Biotherapeutics C formerly Bayer) Patient Information
No information avaliable
Prolastin (Talecris Biotherapeutics C formerly Bayer) Organisms Affected
Humans and other mammals
